What's breaking now, across thousands of outlets.
New TB jabs in the pipeline have the potential of becoming the "next blockbuster immunisation tool", said Sania Nishtar, head of the Gavi global vaccine alliance.
We haven't written up this one. ETHealthworld has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
New tuberculosis vaccines expected from 2029 could save over seven million lives by 2050, according to the Gavi vaccine alliance, if supply is ensured.
New TB vaccines could avert up to 7.3 million deaths between 2030 and 2050, but Gavi says affordable, reliable supply will be crucial in high-burden countries.
New TB vaccines could deliver billions in economic benefits while helping curb the world's deadliest infectious disease.
John Harbaugh has a weird way of trying to prove a point.
There is a lot going on in the GLP-1 space, a market that landed $79 billion last year, and could shift significantly in the coming years.
Projected by some analysts as a future blockbuster, Isembyld is the first “muscle-targeted” treatment for the disease and, in clinical testing, helped improve motor function in people on standard…
